Relationship between solubility of grifolan, a fungal 1,3-β-D-glucan, and production of tumor necrosis factor by macrophages in vitro

被引:62
作者
Ishibashi, K [1 ]
Miura, NN [1 ]
Adachi, Y [1 ]
Ohno, N [1 ]
Yadomae, T [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 1920392, Japan
关键词
beta-glucan; grifolan; tumor necrosis factor; macrophage; molecular mass;
D O I
10.1271/bbb.65.1993
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Grifolan, GRN, is a fungal antitumor fl-glucan isolated from Grifola frondosa. Various studies suggested that the underlying mechanism of the antitumor activity of GRN is strongly related to immune modulation. In the previous publication (Adachi et al., 1994; Okazaki et al., 1995), we have shown that GRN activates macrophages to produce tumor necrosis factor (TNF) in vitro. In this study, the structural unit essential to produce TNF was examined by chemical modifications of GRN. GRN suspended in distilled water was treated at 150 degreesC for up to 3 h. Addition of the resulting turbid solution to the RAW 264.7 macrophage-like cell line produced TNF, and the relative activity was diminished in relation to the heat treatment period. The fractions with a heating period longer than 15 min did not show any activity. After centrifugation of the resulting solution, significant activity was shown by precipitate fractions, suggesting that the insoluble form of GRN is important for TNF production. Interestingly, the precipitate fraction obtained from 9 min of treatment also had significant activity. In addition, admixing the soluble fraction with the particles significantly inhibited the TNF production. In contrast to these observations, the high-molecular-mass subfraction of the soluble fraction prepared by ultrafiltration produced significant amounts of TNF. Similar phenomena were shown with sodium hydroxide treatment and dimethylsulfoxide treatment. These facts strongly suggested that insoluble as well as a high molecular mass soluble form of GRN are required for TNF production by macrophages.
引用
收藏
页码:1993 / 2000
页数:8
相关论文
共 30 条
[21]  
OHNO N, 1987, CHEM PHARM BULL, V35, P2180
[22]  
OKAZAKI M, 1995, BIOL PHARM BULL, V18, P1320, DOI 10.1248/bpb.18.1320
[23]  
OZINSKY A, 2000, P NATL ACAD SCI USA, V95, P9825
[24]   ACTIVATION OF THE COMPLEMENT-SYSTEM BY (1-]3)-BETA-D-GLUCANS HAVING DIFFERENT DEGREES OF BRANCHING AND DIFFERENT ULTRASTRUCTURES [J].
SUZUKI, T ;
OHNO, N ;
SAITO, K ;
YADOMAE, T .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1992, 15 (06) :277-285
[25]  
Tsuzuki A, 1999, DRUG DEVELOP RES, V48, P17, DOI 10.1002/(SICI)1098-2299(199909)48:1<17::AID-DDR3>3.0.CO
[26]  
2-N
[27]   Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses [J].
Vassallo, R ;
Standing, JE ;
Limper, AH .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3755-3763
[28]   Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells [J].
Vetvicka, V ;
Thornton, BP ;
Ross, GD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :50-61
[29]  
Xia Y, 1999, J IMMUNOL, V162, P2281
[30]  
Yadomae T., 1996, RECENT RES DEV CHEM, V1, P23